Clinical Trials Directory

Trials / Unknown

UnknownNCT05297422

Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration

Administration of Ketamine to Branchial Plexus Block Using Axillary Approach : Comparative Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
81 (estimated)
Sponsor
National and Kapodistrian University of Athens · Academic / Other
Sex
All
Age
16 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess Ketamine as an adjuvant to Branchial Plexus Blockade.

Detailed description

After being informed about the study, patients giving written informed consent will undergo anaesthesia using the Ultrasound Guided Axillary Approach to Brachial Plexus Blockade, in order to undergo forearm surgery. The purpose of this study is to assess whether Ketamine as an adjuvant lengthens sensory and motor blockade and whether it has an effect on "rebound pain" when the anaesthetic effect fades. Therefore the study will compare intravenous, regional and no administration of Ketamine as an adjuvant to Branchial Plexus Blockade. Patients will be asked to fill in a Pain VAS (Visual Analog Scale) for 24 hours following the intervention, in order to assess effectiveness of each anaesthetic method. Side effects, onset time, motor blockade score and rescue dose are also recorded.

Conditions

Interventions

TypeNameDescription
PROCEDUREForearm surgeyMicrosurgery Clinic , KAT Hospital Athens
DRUGRopivacaineRopivacaine
DRUGKetamineKetamine

Timeline

Start date
2022-01-20
Primary completion
2023-05-01
Completion
2023-06-01
First posted
2022-03-28
Last updated
2022-03-28

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05297422. Inclusion in this directory is not an endorsement.